Trientine for treatment of Wilson's disease: clinical and cost-effectiveness, and safety
CADTH
Record ID 32014000821
English
Authors' recommendations:
One relevant systematic review and three non-randomized studies were identified regarding the clinical effectiveness and safety of trientine for the treatment of Wilsons disease. No information on cost-effectiveness was identified.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/feb-2014/RA0660%20Trientine%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Hepatolenticular Degeneration
- Cost-Benefit Analysis
- Safety
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.